Research workbench
TETR(D) T103A mutant in complex with anhydrotetracycline and magnesium, I4(1)22
Analyse TETR(D) T103A mutant in complex with anhydrotetracycline and magnesium, I4(1)22 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 5FKM
- Type
- protein
- Length
- 203 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Tetracycline repressor, class D
- UniProt
- C6G9U5
- Ligands
- TDC, MG, CL
- Pockets
- 2 · best druggability 0.65
Structure
x-ray diffraction · 1 distinct chain · 73% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Tetracycline repressor, class D | protein | 203 | 73% helix, 0% strand | C6G9U5 |
Ligands and binding sites
- TDC · 5A,6-anhydrotetracycline · ligand · chains A
- MG · Magnesium ion · metal · chains A
- CL · Chloride ion · ion · 4 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 269 | 0.65 | 0.82 | 32 | TDC, MG |
| 2 | 50 | 0.33 | 0.78 | 11 | empty |
Compared structures
- 5FKM · TetR(D) T103A mutant in complex with anhydrotetracycline and magnesium, I4(1)22 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt C6G9U5
- Elsewhere: RCSB PDB 5FKM · PDBe 5FKM · UniProt C6G9U5
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.